Obafistat
Obafistat is a potent aldo-keto reductase AKR1C3 inhibitor with an IC50 of 1.2 nM for human AKR1C3 (patent WO2017202817A1, example 4) [1].
Product Specifications
CAS Number
2160582-57-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/obafistat.html
Purity
99.92
Solubility
DMSO : 62.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N1CC(N2S(=O)(C3=CC=CC(F)=C3)=O)CCC2C1)C4=CN=NN4
Molecular Formula
C15H16FN5O3S
Molecular Weight
365.38
Precautions
H302, H315, H319
References & Citations
[1]Marcus Koppitz, et al. [8- (phenylsulfonyl) -3,8-diazabicyclo[3.2.1]oct-3-yl] (1h-1,2,3-triazol-4-yl) methanones. WO2017202817A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740977-100 1x 100 µL
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880204-500 1x 500 µL
Complement C4d (C4D204), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470525-100 1x 100 µL
CD63 (MX-49.129.5), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
